View in EDS HTML Full Text PDF Full Text

Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors.

Saved in:
Bibliographic Details
Title: Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors.
Authors: Deslais, Martin1 (AUTHOR), Koenig, Alice1,2 (AUTHOR), Buron, Fanny1 (AUTHOR), Ouellet, Gabriel1 (AUTHOR), Rabeyrin, Maud3 (AUTHOR), Picard, Cécile3 (AUTHOR), Dijoud, Frédérique3 (AUTHOR), Snanoudj, Renaud4 (AUTHOR), Zaidan, Mohamad4 (AUTHOR), von Tokarski, Florent5 (AUTHOR), Eddine, Arwa Jalal5 (AUTHOR), Le Quintrec, Moglie6 (AUTHOR), Serre, Jean-Emmanuel6 (AUTHOR), Corbel, Alice7 (AUTHOR), Flahault, Adrien7 (AUTHOR), Giral, Magali8,9 (AUTHOR), Masset, Christophe8,9 (AUTHOR), Anglicheau, Dany10 (AUTHOR), Aubert, Olivier10 (AUTHOR), Sicard, Antoine11 (AUTHOR)
Source: Transplant International. 2026, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09340874
DOI:10.3389/ti.2026.15318